Global Pulse

分类： health

  • ‘The answer cannot be nothing’: The battle over Canada’s mystery brain disease

    ‘The answer cannot be nothing’: The battle over Canada’s mystery brain disease

    A perplexing medical saga unfolding in Canada’s New Brunswick province has sparked intense debate between patients, physicians, and scientific authorities regarding the existence of a mysterious neurological condition affecting hundreds of residents.

    The controversy began in early 2019 when hospital officials identified two patients with Creutzfeldt-Jakob Disease (CJD), a rare and fatal brain disorder. While the CJD cases were contained, neurologist Dr. Alier Marrero revealed he had been documenting patients with similar yet unexplained symptoms for several years. These cases displayed a bewildering array of neurological manifestations including rapid-onset dementia, muscle atrophy, hallucinations, movement disorders, and cognitive impairments—particularly concerning as they appeared in unusually young patients.

    Dr. Marrero’s cluster of suspected cases expanded dramatically from initially 20 to approximately 500 patients over five years. The Cuban-born neurologist, described by patients as exceptionally compassionate and thorough, pursued extensive testing while reporting to Canada’s Creutzfeldt-Jakob Disease Surveillance System. Despite negative results for known prion diseases, Marrero grew convinced of an environmental connection, specifically pointing to glyphosate herbicides used in provincial forestry operations.

    The situation escalated in March 2021 when a leaked government memo brought public attention to the apparent syndrome, dubbed ‘New Brunswick Neurological Syndrome of Unknown Cause.’ Federal scientists initially supported investigation efforts, with the Canadian Institutes of Health Research offering $5 million for research. However, provincial authorities abruptly suspended collaboration and declined the funding, citing concerns about Marrero’s methodologies and what they perceived as circumvention of proper channels.

    Subsequent government investigations concluded in February 2022 that no common environmental cause or unified condition existed among patients. This conclusion was bolstered by a May 2025 study published in JAMA that examined 25 patients from the cluster. The research, led by Toronto neurologist Dr. Anthony Lang, found all patients suffered from previously identified conditions including functional neurological disorder (FND), various dementias, and other established diagnoses. The study attributed the apparent cluster to serial misdiagnosis amplified by media attention, pandemic-related institutional distrust, and limitations in provincial healthcare resources.

    The scientific consensus has sparked outrage among many patients who remain fiercely loyal to Dr. Marrero. Advocates including Bloodwatch director Kat Lanteigne allege a government cover-up of environmental contamination and have challenged the JAMA study’s ethics and methodology. Meanwhile, patients who sought second opinions through the provincially-run Mind Clinic have received diagnoses for conditions such as FND—a complex disorder where psychological factors manifest as physical symptoms without structural neurological damage.

    The human impact remains profound. Several patients have deteriorated significantly, with at least one opting for medical assistance in dying (MAID) and others considering it. Jillian Lucas, who developed symptoms after caring for her affected stepfather, represents those caught between seeking answers and facing deteriorating health: ‘I have a limit in my mind of how far I can go.’

    Dr. Marrero continues to treat patients outside the provincial system, maintaining his conviction about an unidentified neurological syndrome. As debates continue regarding medical ethics, diagnostic accuracy, and environmental safety, hundreds of patients and families await resolution while navigating uncertain medical futures.

  • Dubai: Indian star Samantha Ruth Prabhu urges women to take control of their health decisions

    Dubai: Indian star Samantha Ruth Prabhu urges women to take control of their health decisions

    At the prestigious 1 Billion Summit in Dubai, Indian actress Samantha Ruth Prabhu delivered a powerful call to action for women to reclaim authority over their healthcare decisions. The event, recognized as one of the globe’s largest gatherings for content creators, served as the platform for Prabhu’s heartfelt advocacy stemming from her personal battle with an autoimmune disease.

    Prabhu recounted the profound disorientation she experienced following her diagnosis, describing an initial period of darkness and confusion. “When I first started looking for answers, I found myself in an overwhelming abyss of information without clear direction,” she revealed. Her journey toward healing required a complete two-year hiatus from her acting career—a privilege she acknowledges isn’t available to everyone.

    This recognition inspired the creation of her podcast ‘Take 20’, which aims to democratize access to evidence-based health information. Through expert interviews and candid discussions, the podcast provides listeners with the tools to navigate their wellness journeys with confidence and clarity.

    The panel discussion featured insights from celebrity nutritionist Mona Sharma and wellness advocate Shayoon, who expanded on the systemic challenges in women’s healthcare. Sharma highlighted how medical frameworks have historically been designed through a male-centric lens, leading to the dismissal of women’s symptoms. “Technology now enables us to access female-specific research and data that was previously nonexistent,” Sharma noted, emphasizing how digital tools can personalize healthcare understanding.

    Shayoon addressed the emotional dimensions of wellness, pointing out that many high-achieving women silently endure chronic stress. She advocated for morning gratitude practices and 40-minute daily meditation sessions as foundational to emotional and physical health. “The prerequisite to everything is addressing what’s happening emotionally,” she asserted. “Without this foundation, reaching one’s highest potential remains elusive.”

    Together, these voices formed a unified message: women must challenge outdated medical norms, leverage technology for personalized health insights, and prioritize emotional wellbeing as the cornerstone of comprehensive health management.

  • Novel pay systems to aid medical access

    Novel pay systems to aid medical access

    China’s National Healthcare Security Administration has unveiled an ambitious three-year plan to transform medical insurance payments through advanced digital integration. The initiative aims to address longstanding inefficiencies in healthcare reimbursement systems by implementing a comprehensive payment platform combining facial recognition, one-code scanning, mobile, and credit-based options.

    The innovative framework will streamline outpatient, emergency, and inpatient services nationwide. Facial recognition technology will particularly benefit elderly patients who often struggle with physical cards or smartphone applications. The one-code system consolidates insurance reimbursement, personal account deductions, and out-of-pocket expenses into a single transaction, while mobile payments dramatically reduce waiting times.

    A groundbreaking credit payment component allows banks to cover patients’ medical expenses within pre-approved limits through contractual agreements, creating a ‘treatment first, payment later’ model. Provincial authorities will pilot the system in at least two cities each throughout 2026, with full implementation across all designated insurance hospitals targeted for 2028.

    Early implementations demonstrate promising results. Hami City in Xinjiang launched China’s first regional credit payment program in early 2025, offering residents up to ¥5,000 ($716) in interest-free medical credit. Within its initial month, the program attracted 120 users and processed 538 transactions totaling ¥43,000. Similarly, Dalian in Liaoning province has successfully integrated insurance and personal payments into unified processes across 200 medical institutions, significantly reducing administrative burdens and repeat visits for patients.

  • UAE recalls some Nestle products: How to identify if your infant formula is impacted

    UAE recalls some Nestle products: How to identify if your infant formula is impacted

    In a significant food safety development, Nestlé has announced a widespread recall of multiple infant formula products across eight Middle Eastern and North African countries. The precautionary measure comes after the discovery of potential cereulide toxin contamination in specific production batches, linked to traces of Bacillus cereus bacteria in raw materials.

    The United Arab Emirates’ Emirates Drug Establishment confirmed the recall late Wednesday, identifying affected products including NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1, 2 and 3, Isomil Ultima 1, 2 and 3, and Alfamino formulas. The contamination risk stems from arachidonic acid (ARA) oil, an ingredient used in numerous infant nutrition products globally.

    Gulf Cooperation Council members UAE, Saudi Arabia, Kuwait, and Qatar have officially issued recalls, alongside Bahrain, Egypt, Iran, and Oman. While no confirmed illnesses or adverse events have been reported to date, health authorities emphasize the potential health risks. Cereulide exposure can cause gastrointestinal symptoms including nausea, vomiting, and abdominal cramps in infants.

    Consumers are urged to immediately check their formula containers for batch codes located at the base of the tin. Nestlé has published comprehensive lists of affected batch numbers, which vary by country. Those identifying recalled products should contact their local Nestlé Consumer Engagement Center for refunds or replacements, potentially providing photographic evidence of the product and batch code.

    The multinational corporation is collaborating with regional health authorities to implement appropriate safety measures in accordance with local food safety regulations. Company representatives stress that this proactive recall demonstrates their commitment to consumer protection, though they note the contamination was detected before any health incidents were reported.

    Local Nestlé teams are maintaining updated information on brand-specific websites to keep consumers informed throughout the recall process. Health authorities continue to monitor the situation while reassuring the public that swift action has been taken to mitigate potential health risks.

  • 4 GCC countries recall batches of Nestle’s infant formula

    4 GCC countries recall batches of Nestle’s infant formula

    Four Gulf Cooperation Council (GCC) nations have initiated precautionary recalls of multiple Nestlé infant formula products following the detection of Bacillus cereus bacteria in a raw material ingredient. The contamination scare, which has triggered global health alerts across 37 countries, prompted coordinated action from UAE, Saudi Arabia, Kuwait, and Qatar on January 7th.

    The UAE’s Emirates Authority for Standardization and Metrology (ESMA) announced the recall of specific batches including NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1-3, Isomil Ultima 1-3, and Alfamino formulas. This decisive action came after laboratory analysis revealed traces of cereulide-producing bacteria in production materials, though no illnesses have been reported in connection with the products.

    Saudi Arabia’s Food and Drug Authority (SFDA) simultaneously issued consumption advisories against Nestlé’s NAN, ALFAMINO, S-26 GOLD, and S-26 ULTIMA brands. The authority confirmed implementing comprehensive market withdrawal procedures in coordination with the Swiss food giant, emphasizing that the recall was initiated following Nestlé’s voluntary risk assessment notification.

    Kuwaiti and Qatari health authorities mirrored these precautions, with Kuwait clarifying that affected products were not distributed through the nation’s ration card system. Qatar’s Ministry of Public Health urged consumers to return or dispose of specified batches while maintaining continuous monitoring of laboratory results.

    Nestlé acknowledged the quality issue originated from a third-party supplier’s arachidonic acid oil component. The company has implemented global testing protocols for all potentially impacted oil mixes and established refund mechanisms for concerned consumers. Despite the extensive recall, the multinational corporation maintains that no confirmed illnesses have been linked to the products, characterizing the action as preventive consumer protection measure.

    The coordinated GCC response demonstrates heightened regional food safety vigilance, with all affected nations maintaining open communication channels with the manufacturer while conducting ongoing safety assessments.

  • UAE issues recall for some Nestle infant formula products

    UAE issues recall for some Nestle infant formula products

    The United Arab Emirates has enacted a voluntary product recall for specific batches of Nestlé infant nutrition formulas as a precautionary health measure. This action, coordinated between the Emirates Drug Establishment (EDE) and the global food manufacturer, follows the discovery of a potential microbial contaminant in a raw material used during production.

    The affected products include several lines of specialized infant formula: NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1, 2 and 3, Isomil Ultima 1, 2 and 3, and the Alfamino range. The EDE emphasized that this recall is proactive and preventative, initiated after quality controls detected traces of Bacillus cereus bacteria, which can produce the toxin cereulide.

    This UAE recall forms part of a broader international response, with at least 37 countries across Europe, Africa, the Americas, and Asia having issued similar health advisories regarding these specific batches. National food safety authorities in Brazil, China, South Africa, Mexico, and Australia have all implemented comparable precautionary measures.

    Critical to public reassurance, the EDE confirmed that no illnesses or adverse health events related to these products have been reported within the UAE to date. All other Nestlé products remain unaffected and safe for consumption. The authority detailed that the identified batches have been immediately quarantined within Nestlé’s and distributors’ warehouses. A comprehensive process is now underway to ensure the complete removal of these products from all retail channels, including online marketplaces, to safeguard consumer health and safety in alignment with the nation’s stringent regulatory protocols.

  • More protein, less sugar: Trump administration issues new dietary guidelines

    More protein, less sugar: Trump administration issues new dietary guidelines

    In a significant shift from established nutritional policy, the Trump administration unveiled revised federal dietary guidelines on January 7, 2026, emphasizing increased protein consumption and stringent sugar limitations. The new recommendations mark a departure from conventional wisdom by endorsing full-fat dairy products and explicitly discouraging highly processed foods and artificial sweeteners.

    The guidelines, developed under Health Secretary Robert F. Kennedy Jr. and Agriculture Secretary Brooke Rollins as part of the “Make America Healthy Again” (MAHA) initiative, represent the most substantial overhaul of federal nutrition advice in decades. Secretary Kennedy declared the administration’s stance as a “war on added sugar” during the White House announcement, positioning the new guidelines as a measure to combat rising chronic disease rates linked to dietary patterns.

    Key modifications include increased protein recommendations from 0.8 grams to 1.2-1.6 grams per kilogram of body weight daily, elimination of specific alcohol consumption limits in favor of general reduction advice, and removal of the previous allowance for minimal added sugars in healthier foods. The updated guidance now states that “no amount of added sugars or non-nutritive sweeteners is recommended or considered part of a healthy or nutritious diet.”

    The administration’s approach has drawn support from medical organizations, including the American Medical Association, which applauded the focus on processed foods and sugar-sweetened beverages contributing to heart disease, diabetes, and obesity. However, the guidelines have generated controversy due to their departure from previous scientific consensus and concerns about industry influence on nutritional policy.

    These federally-mandated guidelines form the nutritional foundation for school meal programs serving approximately 30 million children and influence medical advice nationwide. The administration has indicated plans to reform the guideline development process further, including restructuring advisory committees that critics claim have been overly influenced by food industry interests.

  • Study shows how fast kilos return after ending weight-loss drugs

    Study shows how fast kilos return after ending weight-loss drugs

    A comprehensive medical review published Thursday in The BMJ reveals that patients who discontinue next-generation weight-loss medications regain previously lost weight at an accelerated rate compared to those ending traditional diet and exercise regimens. The study, conducted by Oxford University researchers, represents the most extensive analysis to date on weight rebound patterns following cessation of GLP-1 agonist drugs like Ozempic and Wegovy.

    According to the research, individuals who stopped taking semaglutide-based medications experienced weight regain at approximately four times the velocity of those abandoning conventional weight management programs. Participants in clinical trials had initially lost an average of 15 kilograms while actively using these pharmaceutical interventions. However, within one year of discontinuation, they regained approximately 10 kilograms, with projections indicating complete return to baseline weight within 18 months.

    The investigation synthesized data from 37 distinct studies examining various weight-loss pharmaceuticals, finding consistent patterns of 0.4 kilograms regained monthly after treatment cessation. Notably, cardiovascular health metrics including blood pressure and cholesterol levels similarly reverted to pre-treatment baselines within 1.4 years post-discontinuation.

    Study co-author Susan Jebb, Professor of Public Health Nutrition at Oxford University, emphasized that approximately half of patients discontinue these medications within the first year, potentially due to side effects like nausea or substantial financial burden—costs can exceed $1,000 monthly in the United States.

    Researchers clarified that while the rapid weight regain partially reflects the substantial initial weight loss achieved through pharmaceutical intervention, separate analysis confirmed that rebound velocity remained consistently faster after medication cessation regardless of initial weight reduction magnitude. This suggests that behavioral modifications through diet and exercise programs may create more sustainable lifestyle changes.

    The findings have significant implications for healthcare systems evaluating the long-term cost-effectiveness of these treatments. Experts emphasize that obesity should be approached as a chronic relapsing condition requiring lifelong management strategies rather than temporary interventions. University of Melbourne metabolic neuroscience researcher Garron Dodd, while not involved in the study, noted that sustainable treatment will likely require combination approaches and therapies that fundamentally reshape neural pathways governing energy balance.

  • UAE moves towards nationwide mandatory early cancer screening, says Minister

    UAE moves towards nationwide mandatory early cancer screening, says Minister

    The United Arab Emirates is advancing a federal strategy to implement compulsory early cancer detection screenings across the nation, connecting participation directly to health insurance requirements. Health Minister Ahmed Al Sayegh announced this significant healthcare policy shift during a Federal National Council session on Wednesday, January 7, 2026.

    Minister Al Sayegh emphasized that early cancer detection represents one of the most effective approaches for enhancing survival rates while simultaneously reducing both the economic burden and long-term health consequences of cancer. This initiative emerges amid increasing global cancer incidence rates.

    Abu Dhabi’s pioneering ‘Ifhas’ program serves as the model for this nationwide expansion. This comprehensive screening framework currently covers citizens from age 18, conducting evaluations every two to three years—or more frequently based on individual medical risk profiles. The program targets several prevalent cancers including breast, colorectal, cervical, and lung cancer, alongside preventive testing for chronic conditions such as diabetes, cardiovascular disease, and hypertension.

    The federal expansion involves standardizing preventive screening protocols across all emirates. The ‘Itmi’nan’ program, operated by Emirates Health Services, provides periodic screening for non-communicable diseases and certain cancers, and is being integrated into standard healthcare pathways with plans for enhanced scope and coverage.

    The UAE is increasingly employing cutting-edge diagnostic technologies including liquid biopsies, genetic testing, advanced laboratory diagnostics, and artificial intelligence-supported medical imaging. These technologies enable more accurate and rapid diagnoses, facilitating earlier clinical interventions and allowing healthcare providers to implement risk-based, personalized screening protocols rather than relying exclusively on age-based testing models.

    Looking toward the future, Minister Al Sayegh highlighted the National Genome Programme’s role in advancing preventive healthcare. This initiative will help medical teams identify genetic risk factors that might necessitate early monitoring or intervention, reflecting a broader national shift toward evidence-based, proactive healthcare supported by scientific and technological innovation.

    FNC member Naama Al Sharhan endorsed these efforts while emphasizing the need for stronger participation rates, particularly for cancers with high mortality rates. She noted that early detection not only improves treatment outcomes but also reduces the emotional and financial strain on families.

    The Ministry of Health and Prevention continues to refine its preventive health strategy in coordination with federal and local partners, aiming to protect public health and ensure the healthcare system’s long-term sustainability in alignment with international best practices.

  • New US dietary guidelines call for more protein, less processed food

    New US dietary guidelines call for more protein, less processed food

    The U.S. Department of Health and Human Services has introduced transformative dietary recommendations that fundamentally reshape national nutrition policy. Secretary Robert F. Kennedy Jr. presented the updated guidelines during a White House briefing, championing a “real food” philosophy that encourages increased protein consumption while dramatically reducing processed foods and added sugars.

    The comprehensive guidelines, revised quinquennially through collaboration between the Agriculture Department and Health and Human Services, now endorse three daily servings of full-fat dairy products and significantly modify alcohol consumption recommendations. These nutritional standards form the cornerstone of federal nutrition initiatives, including the National School Lunch Program and other feeding assistance programs.

    Notable shifts include the abandonment of previous low-fat dairy recommendations in favor of full-fat alternatives, representing a substantial departure from decades of nutritional guidance. The updated framework promotes olive oil as a primary cooking fat while surprisingly suggesting beef tallow—a Kennedy preference—as an acceptable alternative despite its high saturated fat content.

    Alcohol guidelines have undergone the most radical transformation, eliminating specific daily drink limits (previously one drink for women and two for men) in favor of a generalized recommendation to consume “less alcohol for better overall health.” The guidelines maintain specific prohibitions for pregnant women, those recovering from alcohol use disorder, and individuals taking incompatible medications.

    The medical community has responded with divided perspectives. The American Medical Association praised the emphasis on reducing processed foods and sugar-sweetened beverages, with President Bobby Mukkamala declaring that “the guidelines affirm that food is medicine.” However, prominent nutrition experts like former NYU professor Marion Nestle criticized the protein recommendations as unnecessary given existing consumption patterns, warning that the guidelines resemble 1950s eating patterns associated with rampant heart disease.

    The American Heart Association expressed concern that recommendations regarding salt seasoning and red meat consumption might lead consumers to exceed established limits for sodium and saturated fats—primary contributors to cardiovascular disease. These guidelines represent Kennedy’s continued focus on combating obesity and chronic illness, following his previous initiatives regarding artificial food dyes and controversial changes to vaccine policies.